Genomics

Dataset Information

0

Mutagenesis sensitizes murine models of triple negative breast cancer to immunotherapy

ABSTRACT: Mutagenesis sensitizes murine models of triple negative breast cancer to immunotherapy

PROVIDER: PRJNA561596 | ENA |

REPOSITORIES: ENA

Json Xml

Dataset's files

Source:
Action DRS
SRR10069035_1.fastq.gz Fastqsanger.gz
SRR10069035_2.fastq.gz Fastqsanger.gz
SRR10069036_1.fastq.gz Fastqsanger.gz
SRR10069036_2.fastq.gz Fastqsanger.gz
SRR10069037_1.fastq.gz Fastqsanger.gz
Items per page:
1 - 5 of 32

Similar Datasets

Transcriptomics Mutagenesis sensitizes murine models of triple negative breast cancer to immunotherapy
2019-11-13 | GSE136206 | GEO
Genomics Blocking Fra-1 sensitizes triple-negative breast cancer to olaparib
| PRJNA629373 | ENA
Other NF-kB associated markers of PD-1 immunotherapy response in early and metastatic triple negative breast cancer
2024-10-30 | GSE279896 | GEO
Genomics SHP2 Blockade Sensitizes Metastatic Triple Negative Breast Cancer to PI3K Inhibition
| PRJNA526210 | ENA
Genomics p38MAPKa stromal reprogramming sensitizes metastatic breast cancer to immunotherapy
| PRJNA865030 | ENA
Genomics Pericyte Phenotype Switching Alleviates Immunosuppression and Sensitizes Vascularized Tumors to Immunotherapy in Preclinical Models
| PRJNA1132134 | ENA
Genomics Combination therapies to improve the efficacy of immunotherapy in triple-negative breast cancer
| PRJNA954411 | ENA
Genomics Neo-Adjuvant Oncolytic Virotherapy Prior to Surgery Sensitizes Triple-Negative Breast Cancer to Immune Checkpoint Therapy
| PRJNA413701 | ENA
Genomics Combination therapies to improve the efficacy of immunotherapy in triple-negative breast cancer [ATAC-seq]
2023-08-15 | GSE229426 | GEO
Transcriptomics Combination therapies to improve the efficacy of immunotherapy in triple-negative breast cancer [RNA-seq]
2023-08-15 | GSE229422 | GEO